Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial

PURPOSE: The long-term update of US GI Intergroup RTOG 98-11 anal cancer trial found that concurrent chemoradiation (CCRT) with fluorouracil (5-FU) plus mitomycin had a significant impact on disease-free survival (DFS) and overall survival (OS) compared with induction plus concurrent 5-FU plus cispl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gunderson, Leonard L., Moughan, Jennifer, Ajani, Jaffer A., Pedersen, John E., Winter, Kathryn A., Benson, Al B., Thomas, Charles R., Mayer, Robert J., Haddock, Michael G., Rich, Tyvin A., Willett, Christopher G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938865/
https://ncbi.nlm.nih.gov/pubmed/24035327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.07.035
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi